Clinical trial
Cross Sectional Study to Evaluate the Acceptability of Oral Solution of…
NCT00319605 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00319605 |
|---|---|
| Title | Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam |
| Official title | Cross Sectional Study to Evaluate the Acceptability of Oral Solution of Levetiracetam (Keppra®) (SOLUCION Study) |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 600 |
| Start date | Apr 1, 2006 |
| Primary completion | Jul 1, 2006 |
| Completion | Jul 1, 2006 |
| First posted | Apr 27, 2006 |
| Last update posted | May 25, 2012 |
| Countries | Spain |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: